(NASDAQ:DXCM), ATLANTA, Oct. 28, 2025 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information, including allegations that: (i) DexCom had made material design changes to the […]

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of DexCom, Inc. (DXCM) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm GlobeNewswire October 28, 2025 ATLANTA, Oct. 28, 2025 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM).

NEW YORK, NY / ACCESS Newswire / October 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Protalix BioTherapeutics, Inc. ("Protalix BioTherapeutics, Inc.") (NYSE:PLX) concerning possible violations of federal securities laws. On October 17, 2025, Protalix and Chiesi Global Rare Diseases, Protalix’s partner in "the development, production and commercialization

$3.4 million upfront with up to an additional $6.6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants Genprex, Inc.(“Genprex” or the “Company”) (NASDAQ:GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has entered into definitive agreements for

(NASDAQ:ATYR), LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire October 28, 2025 LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ:

NEW YORK, NY / ACCESS Newswire / October 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zions Bancorporation, National Association ("Zions Bancorporation, National Association") (NASDAQ:ZION) concerning possible violations of federal securities laws. Bloomberg published a report on October 16, 2025, titled, "Zions, Western Alliance Banks Disclose Bad Loans

SailGP has announced a new global commercial partnership with Fever, the leading live-entertainment discovery platform. Starting with the 2026 season and running through 2028, Fever will become SailGP's Official Ticketing Partner, helping fans everywhere discover, book, and enjoy SailGP events like never before. Through this multi-season deal, Fever will bring its digital-first ticketing technology and

Children of Fallen Patriots Foundation is proud to announce Major General Richard Johnson as its new Chief Executive Officer, effective in the new year, upon his retirement from the U.S. Army. Outgoing CEO David Kim will remain closely involved as Chairman of the Board of Directors, ensuring a seamless handoff and continued strategic guidance. Cynthia

NEW YORK, NY / ACCESS Newswire / October 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Jefferies Financial Group Inc. ("Jefferies Financial Group Inc.") (NASDAQ:JEF) concerning possible violations of federal securities laws. On October 8, 2025, Jefferies announced that it and Point Bonita had approximately $715 million in